Marta Bellotti

Marta Bellotti

Auto-generated profile, based on publicly available information

Marta Bellotti

Department of Experimental Medicine, Section of Biochemistry, University of Genoa, Viale Benedetto XV 1, 16132 Genoa, Italy; Center of Excellence for Biomedical Research (CEBR), University of Genoa, Viale Benedetto XV 5, 16132 Genoa, Italy

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2013 in Cell Reports
Verified
Journal Article
Open access
FSFrancesca Schena
Francesca Schena
SVstefano volpi
stefano volpi
CFCaterina Elisa Faliti
Caterina Elisa Faliti
FPFederica Penco
Federica Penco
Spartaco SantiSpartaco Santi
Spartaco Santi
ETElisabetta Traggiai
Elisabetta Traggiai
Immunoglobulin (Ig) isotype diversification by class switch recombination (CSR) is an essential process for mounting a protective humoral immune response. Ig CSR deficiencies in humans can result from an intrinsic B cell defect; however, most of these deficiencies are still molecularly undefined and diagnosed as common variable immunodeficiency (CVID). Here, we show that extracellular adenosine critically contributes to CSR in human naive and IgM memory B cells. In these cells, coordinate stimulation of B cell receptor and toll-like receptors results in the release of ATP stored in Ca(2+)-sensitive secretory vesicles. Plasma membrane ectonucleoside triphosphate diphosphohydrolase 1 CD39 and ecto-5'-nucleotidase CD73 hydrolyze ATP to adenosine, which induces CSR in B cells in an autonomous fashion. Notably, CVID patients with impaired class-switched antibody responses are selectively deficient in CD73 expression in B cells, suggesting that CD73-dependent adenosine generation contributes to the pathogenesis of this disease.

1 September 2015 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
GSGiovanna Sociali
Giovanna Sociali
LGLauretta Galeno
Lauretta Galeno
MPMarco Daniele Parenti
Marco Daniele Parenti
AGAlessia Grozio
Alessia Grozio
IBInga Bauer
Inga Bauer
ARAlberto Del Rio
Alberto Del Rio

1 June 2015 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
EPEmanuela Pesce
Emanuela Pesce
MBMarta Bellotti
Marta Bellotti
NLNara Liessi
Nara Liessi
SGSara Guariento
Sara Guariento
GDGianluca Damonte
Gianluca Damonte
Enrico MilloEnrico Millo
Enrico Millo

24 August 2013 in Nucleic Acid Therapeutics
Verified
Journal Article
Closed access
AGAlessia Grozio
Alessia Grozio
Victor GonzalezVictor Gonzalez
Victor Gonzalez
Enrico MilloEnrico Millo
Enrico Millo
LSLaura Sturla
Laura Sturla
TVTiziana Vigliarolo
Tiziana Vigliarolo
EZElena Zocchi
Elena Zocchi
The hormone abscisic acid (ABA) is a small molecule involved in pivotal physiological functions in higher plants. Recently, ABA has been also identified as an endogenous hormone in mammals, regulating different cell functions including inflammatory processes, stem cell expansion, insulin release, and glucose uptake. Aptamers are short, single-stranded (ss) oligonucleotidesable to recognize target molecules with high affinity. The small size of the ABA molecule represented a challenge for aptamer development and the aim of this study was to develop specific anti-ABA DNA aptamers. Biotinylated abscisic acid (bio-ABA) was immobilized on streptavidin-coated magnetic beads. DNA aptamers against bio-ABA were selected with 7 iterative rounds of the systematic evolution of ligands by exponential enrichment method (SELEX), each round comprising incubation of the ABA-binding beads with the ssDNA sequences, DNA elution, electrophoresis, and polymerase chain reaction (PCR) amplification. The PCR product was cloned and sequenced. The binding affinity of several clones was determined using bio-ABA immobilized on streptavidin-coated plates. Aptamer 2 and aptamer 9 showed the highest binding affinity, with dissociation constants values of 0.98±0.14 μM and 0.80±0.07 μM, respectively. Aptamers 2 and 9 were also able to bind free, unmodified ABA and to discriminate between different ABA enantiomers and isomers. Our findings indicate that ssDNA aptamers can selectively bind ABA and could be used for the development of ABA quantitation assays.

1 January 2015 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
MBMarta Bellotti
Marta Bellotti
ASAnnalisa Salis
Annalisa Salis
AGAlessia Grozio
Alessia Grozio
GDGianluca Damonte
Gianluca Damonte
TVTiziana Vigliarolo
Tiziana Vigliarolo
Enrico MilloEnrico Millo
Enrico Millo

1 December 2011 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
AGAlessia Grozio
Alessia Grozio
Enrico MilloEnrico Millo
Enrico Millo
LGLucrezia Guida
Lucrezia Guida
TVTiziana Vigliarolo
Tiziana Vigliarolo
MBMarta Bellotti
Marta Bellotti
EZElena Zocchi
Elena Zocchi